Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Jul;121(1):1-2.
doi: 10.1038/s41416-019-0484-8. Epub 2019 Jun 7.

Cancer screening and prevention in BRCA mutation carriers: a missed opportunity?

Nathalie LeVasseur  1 , Stephen Chia  2
Affiliations
Editorial

Cancer screening and prevention in BRCA mutation carriers: a missed opportunity?

Nathalie LeVasseur et al. Br J Cancer. 2019 Jul.

Abstract

While the elevated lifetime risk of breast and ovarian cancer is well recognised for patients with a BRCA mutation, the implementation of effective risk reduction strategies has been fraught with challenges. This report from an international database and published in the British Journal of Cancer reveals suboptimal rates of utilisation of surveillance/preventative measures globally.

PubMed Disclaimer

Conflict of interest statement

S.C. is a member of the Editorial Board of the British Journal of Cancer. N.L. declares no competing interests.

Comment on

References

    1. Tung N, Lin NU, Kidd J, Allen BA, Singh N, Wenstrup RJ, et al. Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer. J. Clin. Oncol. 2016;34:1460–1468. doi: 10.1200/JCO.2015.65.0747. - DOI - PMC - PubMed
    1. Daly MB, Pilarski R, Berry M, Buys SS, Farmer M, Friedman S, et al. NCCN guidelines insights: genetic/familial high-risk assessment: breast and ovarian, Version 2.2017. J. Natl Compr. Cancer Netw. 2017;15:9–20. doi: 10.6004/jnccn.2017.0003. - DOI - PubMed
    1. Paluch-Shimon S, Cardoso F, Sessa C, Balmana J, Cardoso MJ, Gilbert F, et al. Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening. Ann. Oncol. 2016;27(suppl 5):v103–v110. doi: 10.1093/annonc/mdw327. - DOI - PubMed
    1. Den Heijer M, van Asperen CJ, Harris H, Nippert I, Schmidtke J, Bouhnik AD, et al. International variation in physicians’ attitudes towards prophylactic mastectomy-comparison between France, Germany, the Netherlands and the United Kingdom. Eur. J. Cancer. 2013;49:2798–2805. doi: 10.1016/j.ejca.2013.04.025. - DOI - PubMed
    1. Metcalfe KA, Birenbaum-Carmeli D, Lubinski J, Gronwald J, Lynch H, Moller P, et al. International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. Int. J. Cancer. 2008;122:2017–2022. doi: 10.1002/ijc.23340. - DOI - PMC - PubMed